Evaluating only Biome Bioplastics’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. That’s exactly how it died.
Key Events Timeline
FOUNDING
Biome Bioplastics founded in Southampton to develop home-compostable plant-based plastics.
FUNDING
Raises £5M on AIM to scale manufacturing of biopolymer resins for UK food packaging market.
PIVOT
Pivots to focus on coffee capsules and single-use packaging following UK plastic ban announcements.
SHUTDOWN
Enters administration; bioplastic products priced 3-5x above conventional plastics with no viable path to parity.
Full Analysis
Free · no account needed
Documented cause
Biome Bioplastics, listed on AIM London since 2010, spent over £30M developing plant-based plastic alternatives for packaging and consumer goods. By 2023, the company entered administration after failing to achieve commercial scale. Despite strong ESG tailwinds, bioplastics faced a fatal cost gap vs. petroleum plastics, and major FMCG customers including Sainsbury's and Costa Coffee chose cheaper alternatives or postponed sustainability commitments.
Lesson
“Bioplastics need both retail mandates and feedstock cost breakthroughs to survive — neither alone is enough.”
Failure anatomy
Collapse type
Bankruptcy
📉 MEDIUM
// engine intelligence on Biome Bioplastics
Tier 1 · instant unlock🔒 free account
Loading engine analysis…
Tier 2 · the productAnalyst · €149/mo
What you see retrospectively on Biome Bioplastics, applied predictively to your companies:
→Cross-reference this pattern against your live portfolio
→Alerts when a company you track starts matching this profile